Compare Enovix Corporation (ENVX) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enovix Corporation vs Intuitive Surgical, Inc. — how do they compare? Enovix Corporation trades at $4.66 (market cap $1.11B), while Intuitive Surgical, Inc. trades at $402.88 (market cap $137.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 124.1× Enovix Corporation's market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals.
| ENVX | ISRG | |
|---|---|---|
Market Cap | $1.11B | $137.76B |
Sector | Technology | Health |
52-Week High | $15.93 | $592.85 |
52-Week Low | $4.84 | $379.50 |
Enterprise Value | $1.13B | $133.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVX is trading at $4.59, down 9.29% in the last session, with a bearish technical signal. The company shows consistent quarterly earnings beats but remains deeply unprofitable with a -499.64% net income margin. Recent positive developments include the appointment of a former Apple operations leader as COO and progress in commercial battery production for smart eyewear and smartphone markets.
Despite analyst optimism (75% buy ratings, $12.75 consensus target), ENVX faces significant execution risks as it scales production. The stock offers speculative growth potential in advanced battery technology but requires substantial revenue acceleration to justify current valuations amid persistent cash burn and negative profitability.
Intuitive Surgical (ISRG) trades at $399.75, up 5.34% today, but remains 25% below its 52-week high amid 2026 weakness. The stock shows bearish technical signals with key resistance near $402, while fundamentals remain strong with consistent revenue growth to $10.06B in 2025 and a 28.15% net margin. Recent quarters have seen earnings beats, with Q2 2026 results due July 16. Analyst sentiment is predominantly bullish with a $552.36 price target, though competition concerns persist.
Outlook: Long-term growth prospects in robotic surgery are compelling, supported by da Vinci 5 adoption and AI integration. Near-term risks include margin pressure and competitive threats. The stock offers potential upside if Q2 earnings beat expectations, but volatility may continue until growth catalysts materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
